5:20 PM
 | 
Mar 22, 2013
 |  BC Extra  |  Politics & Policy

BIO, cancer groups attack 'flawed' payment formula

A "flaw" in the way Medicare pays for cancer drugs, exacerbated by a 2% cut in provider payments under budget sequestration, could cause numerous community cancer clinics to close or curtail treatment, according to a letter the Biotechnology Industry Organization (BIO), cancer care...

Read the full 197 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >